source Post navigation Biomea Fusion Announces Dosing of First Type 1 Diabetes Patient in Phase II Study (COVALENT-112) with BMF-219 – GlobeNewswire Community-Level Social Determinants of Health Impact on Risk of Pregestational, Gestational Diabetes – Drug Topics